Skip to Main Content

Author Details

Walid K Chatila
Memorial Sloan Kettering Cancer Center
2017
53
20
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37699004Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer.J Natl Cancer Inst2024
36493333Molecular Classification of Appendiceal Adenocarcinoma.J Clin Oncol2023
37553760GABA Regulates Electrical Activity and Tumor Initiation in Melanoma.Cancer Discov2023
37615936Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer.J Exp Med2023
37503077Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors.Res Sq2023
35766391Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study.Ann Surg2023
37289003The Impact of Germline Alterations in Appendiceal Adenocarcinoma.Clin Cancer Res2023
36990277Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response.Mod Pathol2023
37311462Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination.Mol Cell2023
37406106Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.Clin Cancer Res2023
37034672Distinct tumor architectures for metastatic colonization of the brain.bioRxiv2023
36611031Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers.Nat Commun2023
33214457Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy.Ann Surg2022
35675575Concurrent Germline <i>BRCA1</i>/<i>2</i> and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options.JCO Precis Oncol2022
36441197Clinical features of young onset colorectal cancer patients from a large cohort at a single cancer center.Int J Colorectal Dis2022
35970919Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer.Nat Med2022
35930112Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade.Ann Surg Oncol2022
35247928Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment Initiation.Mol Cancer Ther2022
35235413Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer.JCO Precis Oncol2022
35138918Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts.JCO Precis Oncol2022
32844293Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin.Ann Surg Oncol2021
33795256Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.Clin Cancer Res2021
33545685Tumor Mutational Burden and Mismatch Repair Deficiency Discordance as a Mechanism of Immunotherapy Resistance.J Natl Compr Canc Netw2021
33509808Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas.Clin Cancer Res2021
33833465Respiratory complex and tissue lineage drive recurrent mutations in tumour mtDNA.Nat Metab2021
34885025Early <i>TP53</i> Alterations Shape Gastric and Esophageal Cancer Development.Cancers (Basel)2021
34819518Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights.Nat Commun2021
34611484Ras-p53 genomic cooperativity as a model to investigate mechanisms of innate immune regulation in gastrointestinal cancers.Oncotarget2021
34405229A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.J Natl Cancer Inst2021
33938493A Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Therapy With or Without Panitumumab After Hepatic Resection of KRAS Wild-type Colorectal Cancer.Ann Surg2021
33947930The genomic landscape of carcinomas with mucinous differentiation.Sci Rep2021
33372007Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.Cancer Discov2021
32437664First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial.Lancet Oncol2020
33001300Correction to: Primary Tumor Location and Outcomes After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Peritoneal Metastases of Colorectal Origin.Ann Surg Oncol2020
32798155Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis.Clin Colorectal Cancer2020
32730818Specific Mutations in APC, but Not Alterations in DNA Damage Response, Associate With Outcomes of Patients With Metastatic Colorectal Cancer.Gastroenterology2020
32581366Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma.Mod Pathol2020
30316684FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.Clin Colorectal Cancer2019
31503397Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion.Cancer Med2019
31455678Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma.Clin Cancer Res2019
31337644Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer.Clin Cancer Res2019
31417090Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis.Nat Commun2019
30952642Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer.Clin Cancer Res2019
31152158Publisher Correction: The long tail of oncogenic drivers in prostate cancer.Nat Genet2019
29316426Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.Cancer Cell2018
30013179Genome doubling shapes the evolution and prognosis of advanced cancers.Nat Genet2018
29122777Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.Cancer Discov2018
29337640Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.J Clin Oncol2018
29622466Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.Cancer Cell2018
29625050Oncogenic Signaling Pathways in The Cancer Genome Atlas.Cell2018
  • 1 - 50 of 53

Recommended Authors

Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 28
Sahil Seth
The University of Texas MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 23
Daniela Hirsch
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Career Start Year 2012
Number of shared co-authors 0
Ashton A Connor
Houston Methodist Hospital
Career Start Year 2012
Number of shared co-authors 0
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 19
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 1
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 17
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 2
Rodrigo Dienstmann
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2006
Number of shared co-authors 10
John Paul Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 21
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 8
Eduardo Vilar
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 5
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 2
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 5
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 24
Simon Kreutzfeldt
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2002
Number of shared co-authors 2
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 3
Nikhil Wagle
Dana-Farber Cancer Institute
Career Start Year 2000
Number of shared co-authors 15
Scott Kopetz
University of Texas MD Anderson Cancer Center
Career Start Year 2000
Number of shared co-authors 15
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 23
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 18
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 13
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 2
Siraj M Ali
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 15
Ultan McDermott
Wellcome Sanger Institute
Career Start Year 1993
Number of shared co-authors 7
Remond J A Fijneman
The Netherlands Cancer Institute
Career Start Year 1993
Number of shared co-authors 8
Paul T Fanta
University of California San Diego Moores Cancer Center
Career Start Year 1992
Number of shared co-authors 2

Collaborators

Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 38
Francisco Vega
The University of Texas MD Anderson Cancer Center
Co-authored papers 17
Michael F Berger
Co-authored papers 13
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Ritika Kundra
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Jianjiong Gao
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Joshua Armenia
Oncology R&D
Co-authored papers 5
Konnor La
The Rockefeller University
Co-authored papers 4
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Howard I Scher
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Mithat Gonen
Co-authored papers 3
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 3
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 3
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Chris Sander
Broad Institute of MIT and Harvard
Co-authored papers 3
Azfar Basunia
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 3
Gregory P Way
Broad Institute of MIT and Harvard
Co-authored papers 2
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 2
Giovanni Ciriello
University of Lausanne (UNIL)
Co-authored papers 2
Liying Zhang
The Fifth Affiliated Hospital, Sun Yat-sen University
Co-authored papers 2
Ronglai Shen
Co-authored papers 2
Zachary J Heins
Boston University
Co-authored papers 2
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 2
Rebecca Nagy
Guardant Health Inc.
Co-authored papers 2
Franklin W Huang
Institute for Human Genetics, University of California san francisco
Co-authored papers 2
Susana Miranda
The Institute of Cancer Research
Co-authored papers 2
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Release 1.2